BMRN logo

BioMarin Pharmaceutical (BMRN) Total debt

Annual Total Debt:

$602.71M-$493.04M(-45.00%)
December 31, 2024

Summary

  • As of today (July 1, 2025), BMRN annual total debt is $602.71 million, with the most recent change of -$493.04 million (-45.00%) on December 31, 2024.
  • During the last 3 years, BMRN annual total debt has fallen by -$486.83 million (-44.68%).
  • BMRN annual total debt is now -48.68% below its all-time high of $1.17 billion, reached on December 31, 2017.

Performance

BMRN Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

Quarterly Total Debt:

$601.96M-$753.00K(-0.12%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN quarterly total debt is $601.96 million, with the most recent change of -$753.00 thousand (-0.12%) on March 31, 2025.
  • Over the past year, BMRN quarterly total debt has dropped by -$494.58 million (-45.10%).
  • BMRN quarterly total debt is now -58.75% below its all-time high of $1.46 billion, reached on September 30, 2020.

Performance

BMRN Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

BMRN Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-45.0%-45.1%
3 y3 years-44.7%-44.8%
5 y5 years-29.8%-30.3%

BMRN Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-45.0%at low-45.3%at low
5 y5-year-45.0%at low-58.8%at low
alltimeall time-48.7%>+9999.0%-58.8%>+9999.0%

BMRN Total debt History

DateAnnualQuarterly
Mar 2025
-
$601.96M(-0.1%)
Dec 2024
$602.71M(-45.0%)
$602.71M(+0.0%)
Sep 2024
-
$602.69M(-45.2%)
Jun 2024
-
$1.10B(+0.3%)
Mar 2024
-
$1.10B(+0.1%)
Dec 2023
$1.10B(+0.2%)
$1.10B(+0.0%)
Sep 2023
-
$1.10B(+0.2%)
Jun 2023
-
$1.09B(+0.0%)
Mar 2023
-
$1.09B(-0.0%)
Dec 2022
$1.09B(+0.4%)
$1.09B(+0.2%)
Sep 2022
-
$1.09B(-0.0%)
Jun 2022
-
$1.09B(+0.1%)
Mar 2022
-
$1.09B(+0.1%)
Dec 2021
$1.09B(+0.2%)
$1.09B(+0.2%)
Sep 2021
-
$1.09B(-0.0%)
Jun 2021
-
$1.09B(+0.1%)
Mar 2021
-
$1.09B(+0.0%)
Dec 2020
$1.09B(+26.6%)
$1.09B(-25.5%)
Sep 2020
-
$1.46B(+0.3%)
Jun 2020
-
$1.45B(+68.5%)
Mar 2020
-
$863.08M(+0.5%)
Dec 2019
$858.82M(+3.4%)
$858.82M(+0.6%)
Sep 2019
-
$853.84M(+0.5%)
Jun 2019
-
$849.33M(+0.6%)
Mar 2019
-
$843.98M(+1.6%)
Dec 2018
$830.42M(-29.3%)
$830.42M(-30.8%)
Sep 2018
-
$1.20B(+0.7%)
Jun 2018
-
$1.19B(+0.7%)
Mar 2018
-
$1.18B(+0.7%)
Dec 2017
$1.17B(+71.9%)
$1.17B(+0.7%)
Sep 2017
-
$1.17B(+72.4%)
Jun 2017
-
$676.21M(-2.1%)
Mar 2017
-
$690.93M(+1.1%)
Dec 2016
$683.24M(+3.2%)
$683.24M(+1.1%)
Sep 2016
-
$675.64M(+0.8%)
Jun 2016
-
$670.11M(+0.3%)
Mar 2016
-
$668.01M(+0.9%)
Dec 2015
$662.29M(+3.0%)
$662.29M(-0.8%)
Sep 2015
-
$667.79M(+1.0%)
Jun 2015
-
$661.49M(+0.9%)
Mar 2015
-
$655.49M(+2.0%)
Dec 2014
$642.90M(-1.9%)
$642.90M(-2.1%)
Sep 2014
-
$656.88M(+0.9%)
Jun 2014
-
$650.87M(-1.6%)
Mar 2014
-
$661.42M(+0.9%)
Dec 2013
$655.57M(+88.3%)
$655.57M(+737.1%)
Sep 2013
-
$78.31M(-28.7%)
Jun 2013
-
$109.82M(-0.0%)
Mar 2013
-
$109.85M(-68.5%)
Dec 2012
$348.22M(-0.0%)
$348.22M(-0.0%)
Sep 2012
-
$348.30M(-0.0%)
Jun 2012
-
$348.31M(-0.0%)
Mar 2012
-
$348.33M(-0.0%)
DateAnnualQuarterly
Dec 2011
$348.33M(-7.7%)
$348.33M(-0.0%)
Sep 2011
-
$348.34M(-7.7%)
Jun 2011
-
$377.52M(-0.0%)
Mar 2011
-
$377.52M(0.0%)
Dec 2010
$377.52M(-24.1%)
$377.52M(-29.2%)
Sep 2010
-
$533.41M(+2.3%)
Jun 2010
-
$521.24M(-0.7%)
Mar 2010
-
$524.86M(+5.6%)
Dec 2009
$497.08M(-12.5%)
$497.08M(0.0%)
Sep 2009
-
$497.08M(0.0%)
Jun 2009
-
$497.08M(-12.4%)
Mar 2009
-
$567.40M(-0.1%)
Dec 2008
$567.82M(+14.2%)
$567.82M(+14.2%)
Sep 2008
-
$497.24M(-1.2%)
Jun 2008
-
$503.06M(-0.1%)
Mar 2008
-
$503.37M(+1.2%)
Dec 2007
$497.38M(+115.6%)
$497.38M(-12.9%)
Sep 2007
-
$570.87M(-0.1%)
Jun 2007
-
$571.49M(+131.2%)
Mar 2007
-
$247.23M(+7.2%)
Dec 2006
$230.73M(+2.9%)
$230.73M(-23.1%)
Sep 2006
-
$299.87M(-19.8%)
Jun 2006
-
$374.02M(-5.3%)
Mar 2006
-
$394.88M(+76.1%)
Dec 2005
$224.26M(-17.2%)
$224.26M(-0.8%)
Sep 2005
-
$226.14M(-0.9%)
Jun 2005
-
$228.11M(+34.5%)
Mar 2005
-
$169.66M(-37.4%)
Dec 2004
$270.84M(+116.7%)
$270.84M(+0.0%)
Sep 2004
-
$270.81M(+44.8%)
Jun 2004
-
$187.01M(+49.6%)
Mar 2004
-
$125.00M(0.0%)
Dec 2003
$125.00M(>+9900.0%)
$125.00M(0.0%)
Sep 2003
-
$125.00M(0.0%)
Jun 2003
-
$125.00M(>+9900.0%)
Mar 2003
-
$0.00(0.0%)
Dec 2002
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2002
-
$2.91M(>+9900.0%)
Jun 2002
-
$0.00(-100.0%)
Mar 2002
-
$5.22M(-6.0%)
Dec 2001
$5.55M(+6589.2%)
$5.55M(+2203.7%)
Sep 2001
-
$241.00K(-18.6%)
Jun 2001
-
$296.00K(+289.5%)
Mar 2001
-
$76.00K(-8.4%)
Dec 2000
$83.00K(-25.2%)
$83.00K(-8.8%)
Sep 2000
-
$91.00K(-6.2%)
Jun 2000
-
$97.00K(-5.8%)
Mar 2000
-
$103.00K(-7.2%)
Dec 1999
$111.00K(+11.0%)
$111.00K(+11.0%)
Sep 1999
-
$100.00K(-99.6%)
Jun 1999
-
$26.10M(>+9900.0%)
Mar 1999
-
$100.00K
Dec 1998
$100.00K
-

FAQ

  • What is BioMarin Pharmaceutical annual total debt?
  • What is the all time high annual total debt for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual total debt year-on-year change?
  • What is BioMarin Pharmaceutical quarterly total debt?
  • What is the all time high quarterly total debt for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly total debt year-on-year change?

What is BioMarin Pharmaceutical annual total debt?

The current annual total debt of BMRN is $602.71M

What is the all time high annual total debt for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual total debt is $1.17B

What is BioMarin Pharmaceutical annual total debt year-on-year change?

Over the past year, BMRN annual total debt has changed by -$493.04M (-45.00%)

What is BioMarin Pharmaceutical quarterly total debt?

The current quarterly total debt of BMRN is $601.96M

What is the all time high quarterly total debt for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly total debt is $1.46B

What is BioMarin Pharmaceutical quarterly total debt year-on-year change?

Over the past year, BMRN quarterly total debt has changed by -$494.58M (-45.10%)
On this page